Investigate the safety and efficacy of lymphoma immunotherapy

Not Applicable

Recruiting

• Conditions: lymphoma; Pancreatic carcinoma.; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma; Cancer - Pancreatic

• Registration Number: ACTRN12611000988954
• Lead Sponsor: The First Teaching Hospital, Inner Mongolia Medical College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Karnofsky score> 70; low possible maintenance dose of glucocorticoid therapy (Prednisone 10mg/day, less than one month); no allergy to components of the DCs and CIKs.

Exclusion Criteria

cachexia; HIV positive; drug addictive, pregnant; severe pulmonary and cardiac diseases; history of an autoimmune disorder and prior history of other malignancies

Study & Design

• Study Type: Interventional
• Study Design: Not specified